On February 13, 2018, the Canadian Agency for Drugs and Technologies in Health (CADTH) released a new CDR Update ... Read More
Events
14
Feb2018
08
Feb2018
The pan-Canadian Pharmaceutical Alliance (pCPA) updated the status of negotiations on brand name drugs as of January 31, 2018:
... Read More
07
Feb2018
This is a reminder to patentees of their filing requirements respecting revenues and development expenditures. These filing requirements are contained ... Read More
01
Feb2018
NEW PDCI Report finds Health Canada significantly overstates benefits & underestimates negative impact of its proposed regulatory amendments
/ News, PDCI, What's New
On January 29, 2018, PDCI released a report critically evaluating Health Canada’s plan to change how patented medicine prices ... Read More
30
Jan2018
INESSS Releases Additional Information – Requests for Changes of an Administrative Nature
/ INESSS, Quebec, What's New
On January 29, 2018, Québec’s Institut national d’excellence en santé et en services sociaux (INESSS) released a notice to manufacturers. ... Read More
29
Jan2018
In December 2017, the Governor-in-Council published in Canada Gazette Part 1 the most comprehensive changes affecting patented medicines since Bill ... Read More
22
Jan2018
PMPRB myth busting (I): The imaginary link between Canadian price controls and R&D expenditures
/ Blog, What's New
The myth perpetuated by government and academics – and echoed in the media – is that the Patented Medicine Prices ... Read More
15
Jan2018
The pan-Canadian Pharmaceutical Alliance (pCPA) updated the status of negotiations on brand name drugs as of December 31, 2017:
... Read More